BiotechTubeBiotechTube
Home/Sol-Gel Technologies/Limor Chen
LC

Limor Chen

Vice President, Chief Legal Officer & Corporate Secretary

Sol-Gel Technologies

Therapeutic Areas

DermatologyAcneRosaceaRare Skin Diseases

Sol-Gel Technologies Pipeline

DrugIndicationPhase
TWYNEO® (tretinoin & benzoyl peroxide) creamAcne vulgarisApproved
Epsolay® (benzoyl peroxide) creamPapulopustular RosaceaApproved
SGT-210 (erlotinib) gelEpidermolysis Bullosa Simplex (EBS)Phase 2
SGT-310 (cannabidiol) gelAcne VulgarisPreclinical
SGT-510 (tapinarof) creamAcne VulgarisPreclinical

Leadership Team at Sol-Gel Technologies

AS
Alon Seri-Levy
Chief Executive Officer and Director
GM
Gilad Mamlok
Chief Financial Officer
OT
Ofer Toledano
Chief Operating Officer
DC
David Cohen
Chief Medical Officer
MD
Marc D. Brown
Chief Scientific Officer
SS
Sharon Sagiv
Vice President, Regulatory Affairs
DF
Dror Futter
Vice President, Research & Development
DT
Dov Tamarkin
Director
ND
Nissim Darvish
Chairman of the Board
DO
Dan Oren
Director
View full Sol-Gel Technologies profile